Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases
- PMID: 28011452
- DOI: 10.1136/annrheumdis-2016-210890
Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases
Keywords: Autoantibodies; DMARDs (biologic); Systemic vasculitis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Antineutrophil cytoplasmic antibodies: appropriate use and interpretation.Ann Rheum Dis. 2017 Aug;76(8):e24. doi: 10.1136/annrheumdis-2016-210908. Epub 2017 Jan 2. Ann Rheum Dis. 2017. PMID: 28043997 No abstract available.
Comment on
-
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.Ann Rheum Dis. 2017 Apr;76(4):647-653. doi: 10.1136/annrheumdis-2016-209507. Epub 2016 Aug 1. Ann Rheum Dis. 2017. PMID: 27481830
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
